                         SEQUENCE LISTING

<110>  Shenzhen Institute of Advanced Technology
 
<120>  Use of a neuropeptide in treating bone-injury disease

<130>  AJ21669PCT2201

<160>  17    

<170>  PatentIn version 3.3

<210>  1
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  1

Pro Gln Arg Phe 
1               


<210>  2
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide


<220>
<221>  UNSURE
<222>  (1)..(1)
<223>  Val or Phe

<220>
<221>  UNSURE
<222>  (3)..(3)
<223>  Asn or Ser

<400>  2

Xaa Pro Xaa Leu Pro Gln Arg Phe 
1               5               


<210>  3
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  3

Val Pro Asn Leu Pro Gln Arg Phe 
1               5               


<210>  4
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  4

Pro Leu Arg Phe 
1               


<210>  5
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  5

Ser Gln Ala Phe Leu Phe Gln Pro Gln Arg Phe 
1               5                   10      


<210>  6
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  6

Ser Pro Ala Phe Leu Phe Gln Pro Gln Arg Phe 
1               5                   10      


<210>  7
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  7

Asn Pro Ala Phe Leu Phe Gln Pro Gln Arg Phe 
1               5                   10      


<210>  8
<211>  18
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  8

Ala Gly Glu Gly Leu Asn Ser Gln Phe Trp Ser Leu Ala Ala Pro Gln 
1               5                   10                  15      


Arg Phe 
        


<210>  9
<211>  18
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  9

Ala Gly Glu Gly Leu Ser Ser Pro Phe Trp Ser Leu Ala Ala Pro Gln 
1               5                   10                  15      


Arg Phe 
        


<210>  10
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  10

Gln Phe Trp Ser Leu Ala Ala Pro Gln Arg Phe 
1               5                   10      


<210>  11
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  11

Glu Phe Trp Ser Leu Ala Ala Pro Gln Arg Phe 
1               5                   10      


<210>  12
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  12

Met Pro His Ser Phe Ala Asn Leu Pro Leu Arg Phe 
1               5                   10          


<210>  13
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  13

Met Pro Pro Ser Ala Ala Asn Leu Pro Leu Arg Phe 
1               5                   10          


<210>  14
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  14

Val Pro His Ser Ala Ala Asn Leu Pro Leu Arg Phe 
1               5                   10          


<210>  15
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  15

Val Pro Asn Leu Pro Gln Arg Phe 
1               5               


<210>  16
<211>  18
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  16

Val Asn Met Glu Ala Gly Thr Arg Ser His Phe Pro Ser Leu Pro Gln 
1               5                   10                  15      


Arg Phe 
        


<210>  17
<211>  18
<212>  PRT
<213>  Artificial

<220>
<223>  polypeptide

<400>  17

Ala Asn Met Glu Ala Gly Thr Met Ser His Phe Pro Ser Leu Pro Gln 
1               5                   10                  15      


Arg Phe 
        


